Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 8/26/14 → 8/26/17 |
Funding
- PRA Health Sciences (GS-US-342-1139 // GS-US-342-1139)
- Gilead Sciences, Inc (GS-US-342-1139 // GS-US-342-1139)
Prot # GS-US-342-1139: A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 Weeks with Sofosbuvir and Ribavirin for 12 Weeks in Subjects with Chronic Genotype 2 HCV Inf
- Flamm, Steven L (PD/PI)
Project: Research project